Despite their effectiveness, crosslinking agents come with several challenges. One major issue is the development of drug resistance in cancer cells. Over time, cancer cells can develop mechanisms to repair the DNA damage caused by crosslinks, rendering treatments less effective. Additionally, these agents can also damage healthy cells, leading to side effects such as nephrotoxicity, ototoxicity, and neurotoxicity.
